Skip to content

Clinical results of zoledronic acid in the treatment of osteoporosis

Clinical results of zoledronic acid in the treatment of osteoporosis - Clinical results of zoledronic acid in the treatment of osteoporosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060313
Enrollment
700
Registered
2026-01-15
Start date
2018-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Sponsors

Niimi orthopaedics clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Osteoporosis

Exclusion criteria

Exclusion criteria: Patients who are contraindicated or require cautio Patients who are currently pregnant, breastfeeding, or wish to become pregnant Individuals who cannot provide consent for research

Design outcomes

Primary

MeasureTime frame
Changes in lumbar and proximal femur bone mineral density, changes in bone metabolism markers, incidence of fractures, and incidence of side effects

Countries

Japan

Contacts

Public ContactRUI NIIMI

Niimi orthopaedics surgery clinic Orthopaedic surgery

furikakefuri@hotmail.co.jp08015678442

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026